Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Athens Medical CentreATH:IATR +0.63%56 EV-to-OCF is 57.13 as of Aug. 21, 2026, which is 403% above its 10-year median of 11.35. GuruFocus rates ATH:IATR with a GF Score™ of 56/100 and a GF Value™ of €1.97 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 682 Healthcare Providers & Services companies, Athens Medical Centre ranks worse than 93.11% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Athens Medical Centre's Enterprise Value is €290.7 Mil.
Athens Medical Centre's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €5.1 Mil. Therefore, Athens Medical Centre's EV-to-OCF for today is 57.13.
The historical rank and industry rank for Athens Medical Centre's EV-to-OCF or its related term are showing as below:
ATH:IATR'
s EV-to-OCF Range Over the Past 10 Years
Min: -182.41 Med: 11.35 Max: 2475.33
Current: 57.13
During the past 13 years, the highest EV-to-OCF of Athens Medical Centre was 2475.33. The lowest was -182.41. And the median was 11.35.
ATH:IATR's EV-to-OCF is ranked worse than 93.11% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 8.755
vs ATH:IATR: 57.13
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Athens Medical Centre (ATH:IATR) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Athens Medical Centre's PE Ratio (TTM) for today is calculated as:
Athens Medical Centre's share price for today is €1.61.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Athens Medical Centre's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.054.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Athens Medical Centre's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Athens Medical Centre EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Athens Medical Centre's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Athens Medical Centre's EV-to-OCF falls into.
Athens Medical Centre's current Enterprise Value is €290.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Athens Medical Centre's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €5.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Athens Medical Centre (ATH:IATR) has a EV-to-OCF of 57.13 as of Aug. 21, 2026. This is 403% above median its historical median of 11.35. According to the industry distribution chart, Athens Medical Centre ranks #635 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 93.1%.
Is Athens Medical Centre's EV-to-OCF too high?
Athens Medical Centre's current EV-to-OCF of 57.13 is 403% above median its 10-year median of 11.35. The Healthcare Providers & Services industry median EV-to-OCF is 8.76. Athens Medical Centre's value of 57.13 is 552.5% above this industry median. Based on the distribution chart, Athens Medical Centre ranks #635 out of 682 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Athens Medical Centre has a GF Score™ of 56/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Athens Medical Centre's EV-to-OCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Athens Medical Centre ranks #635 out of 682 companies for EV-to-OCF. This places Athens Medical Centre in the lower half of its industry. The industry median EV-to-OCF is 8.76. Athens Medical Centre's value of 57.13 is 552.5% above this benchmark. While the company's 10-year median is 11.35 vs. the industry median of 8.76, Athens Medical Centre has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.76, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Athens Medical Centre's current EV-to-OCF of 57.13 is 552.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Athens Medical Centre's current EV-to-OCF is 57.13, which is 403% above median its own 10-year median of 11.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athens Medical Centre stock overvalued right now?
Based on GuruFocus' analysis, Athens Medical Centre (ATH:IATR) is currently considered Modestly Undervalued. The stock's GF Value™ is €1.97, compared to a current price of €1.61 — trading 18.3% below its estimated fair value. The current EV-to-OCF is 57.13, which is 403% above median its 10-year median of 11.35 and 552.5% above the Healthcare Providers & Services industry median of 8.76. Athens Medical Centre's overall GF Score™ is 56/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Athens Medical Centre (ATH:IATR), the current EV-to-OCF is 57.13 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Athens Medical Centre (ATH:IATR) Overvalued in 2026?
Based on GuruFocus' analysis, Athens Medical Centre stock appears to be undervalued.
The current stock price of €1.61 is trading 18.3% below its estimated GF Value™ of €1.97.
GuruFocus considers Athens Medical Centre to be Modestly Undervalued.
Key valuation signals for ATH:IATR:
EV-to-OCF: 57.13 (403% above median its 10-year median of 11.35)
GF Value™: €1.97 vs. price of €1.61 (18.3% below fair value)
Industry Position: 552.5% above the Healthcare Providers & Services median (#635 of 682)
No single metric tells the full story. See the ATH:IATR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Athens Medical Centre SA engages in the provision of healthcare services. It includes medical research and methods of treatment, training, and selection of executives and staff on behalf of the hospitals and importation of medical tools, instruments, machinery, and automated devices for the hospitals. Its offering includes medical services in such specializations as pathology, cardiology, general surgery, plastic and vascular surgery, orthopedic, physiotherapy, ophthalmology, urology, neurosurgery, thoracic, pediatric, dermatology, endocrinology and stomatology. The company operates in Domestic healthcare service, Healthcare service provided abroad (Romania) and Sale of medical tools & sanitary/health equipment segment.
56GF Score
Get the complete analysis for ATH:IATR
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ATH:IATR has been successfully added to your 
